Skip to main content
. 2019 Apr 29;11:3681–3690. doi: 10.2147/CMAR.S194176

Table 3.

Adverse events experienced by the patients (N=55)

Adverse events Grade Total
1 or 2 3 or 4
No. % No. % No. %
Gastrointestinal
 Loss of appetite 14 25.4 0 0 14 25.4
 Nausea 18 32.7 0 0 18 32.7
 Vomiting 14 25.4 1 1.8 15 27.2
Hepatic
 Increase of aminotransferase 14 25.4 0 0 14 25.4
 Increase of bilirubin 6 10.9 0 0 6 10.9
Hematologic
 Leucopenia 13 23.6 1 1.8 14 25.4
 Thrombocytopenia 14 25.4 1 1.8 15 27.2
 Decrease of hemoglobin 12 21.8 0 0 12 21.8
Others
 Increase of LDH 2 3.6 0 0 2 3.6
 Increase of creatinase 1 1.8 0 0 1 1.8
 Fever 20 36.4 0 0 20 36.4
 Fatigue 5 9.1 0 0 5 9.1
 Hypertension 2 3.6 0 0 2 3.6
 Trichomadesis 4 7.3 0 0 4 7.3

Abbreviations: No, number; LDH, lactate dehydrogenase.